Related Experiment Video

Updated: May 29, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

Arterial calcification in chronic kidney disease: key roles for calcium and phosphate

Catherine M Shanahan1, Matthew H Crouthamel, Alexander Kapustin

  • 1Department of Bioengineering, University of Washington, Seattle, WA 98195, USA.

Circulation Research
|September 3, 2011
PubMed

Insights

Vascular calcification in chronic kidney disease (CKD) is driven by abnormal calcium and phosphate levels. Elevated phosphate promotes VSMC differentiation, while calcium promotes apoptosis, leading to dangerous vascular calcification.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Cell Biology

Background:

  • Vascular calcification is a major cause of cardiovascular mortality in chronic kidney disease (CKD).
  • Dysregulation of calcium (Ca) and phosphate (P) metabolism is a hallmark of CKD, contributing to vascular calcification.
  • Understanding these metabolic derangements is crucial for managing cardiovascular risk in CKD patients.

Purpose of the Study:

  • To review the physiological mechanisms of Ca and P homeostasis.
  • To explain the basis of Ca and P dysregulation in CKD.
  • To highlight recent findings on the direct effects of elevated Ca and P on vascular smooth muscle cells (VSMCs).

Main Methods:

  • Review of physiological regulatory mechanisms for Ca and P homeostasis.
  • Analysis of the basis for Ca and P dysregulation in CKD.
  • Synthesis of recent research on the cellular effects of elevated Ca and P on VSMCs.

Main Results:

  • Elevated P primarily stimulates osteogenic/chondrogenic differentiation of VSMCs.
  • Elevated Ca predominantly promotes VSMC apoptosis and vesicle release.
  • The combined effects of elevated Ca and P are synergistic, significantly driving vascular calcification in CKD.

Conclusions:

  • Elevated Ca and P directly impact VSMCs, promoting pathways that lead to vascular calcification.
  • Specific roles identified for Ca (apoptosis, vesicle release) and P (differentiation) in vascular calcification.
  • Targeting Ca and P regulatory pathways in VSMCs offers potential therapeutic strategies for CKD patients.

More Related Videos

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models09:01

Analysis of Extracellular Vesicle-Mediated Vascular Calcification Using In Vitro and In Vivo Models

Published on: January 27, 2023

Related Concept Videos

Roles of Electrolytes: Calcium and Phosphate01:27

Roles of Electrolytes: Calcium and Phosphate

Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily regulated...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...